@article{10658,
  keywords = {anticoagulation, Atrial fibrillation, non-vitamin K antagonist oral anticoagulants, off-label dose reduction},
  author = {C. van den Dries and R. Pajouheshnia and H. van den Ham and P. Souverein and K. Moons and A. Hoes and G. Geersing and S. van Doorn},
  title = {Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation},
  year = {2022},
  journal = {Br J Clin Pharmacol},
  edition = {2022/09/15},
  isbn = {0306-5251},
  doi = {10.1111/bcp.15534},
  note = {1365-2125
van den Dries, Carline J
Pajouheshnia, Romin
Orcid: 0000-0002-4208-3583
van den Ham, Hendrika A
Souverein, Patrick
Orcid: 0000-0002-7452-0477
Moons, Karel G M
Hoes, Arno W
Geersing, Geert-Jan
van Doorn, Sander
Journal Article
England
Br J Clin Pharmacol. 2022 Sep 14. doi: 10.1111/bcp.15534.},
  language = {eng},
}